Rivaroxaban Versus Warfarin Treatment Among Morbidly Obese Patients With Venous Thromboembolism: Comparative Effectiveness, Safety, and Costs

Thrombosis Research- United Kingdom

doi 10.1016/j.thromres.2019.08.021

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Elsevier BV

Related search

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders
SurgeryCardiovascular MedicineCardiology
2017English

Costs of Venous Thromboembolism (Vte) Among Hospitalized Patients in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Treatment of Morbidly Obese Psychotic Patients With Molindone

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2009English

Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist

Thrombosis Journal
Hematology
2015English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pharmacokinetic and Pharmacodynamic Evaluation of Rivaroxaban: Considerations for the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2014English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Prevention and Treatment of Venous Thromboembolism in Patients With Cancer

Therapeutic Advances in Hematology
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy